Delivery Order SPE2DB24D3014-SPE2DB25FKRVP

Award Date 10/22/24
Potential Completion Date 10/23/24
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,656.99 and is a Firm Fixed Price Delivery Order for medical supplies, specifically the product "REYVOW 100 MG TABLET UD 8S." The contract has a completion date of February 10, 2025 and was awarded on February 7, 2025. The contract is not designated with a set-aside...
This federal contract award to AmerisourceBergen Drug Corp is a delivery order (SPE2DB20D3103|SPE2DB24FL6R6) with a firm fixed price ceiling value of $1,204.74. The contract is for the supply of REYVOW 100 MG TABLET UD 8S, a pharmaceutical product, with a period of performance through November 28, 2023. The awarding agency is the Defense Logistics Agency (DLA), a defense agency that supports the military's medical and healthcare needs. This contract does not have a set-aside designation,...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $2,452.62, is for the supply of REYVOW 100 MG TABLET UD 8S, a pharmaceutical product, with a completion date of December 16, 2022. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication Reyvow (100 mg tablets). The order has a ceiling value of $1,400.53 and a completion date of May 24, 2023. The contract is a firm fixed-price type and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also holds a...
This federal contract award, SPE2DX22D0029|SPE2D825F19RE, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $3,708.00 fixed-price delivery order contract will run through March 11, 2025 and supports the procurement of a variety of pharmaceutical products and medical supplies, including specialty medications, generic and brand-name drugs, vaccines, syringes, vials, and other medical commodities. Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $23,360.80 firm-fixed-price delivery order is for AREXVY VIAL KITS and has a period of performance through November 4, 2024. The contract is not designated under any set-aside program. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,119.35 contract is for the delivery of REYVOW 100 MG TABLET UD 8S, a prescription medication. The contract has an ultimate completion date of May 24, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This federal contract award is a delivery order (SPEZDB20D2104|SPEZDB25FMAGK) issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,394.39, is for the delivery of the pharmaceutical product UBRELVY 100 MG TABLET UD 10S. The contract has a completion date of October 11, 2024 and is a firm fixed-price contract. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award, SPE2DX22D0029|SPE2D825F07DR, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,063.40 firm-fixed-price delivery order has a completion date of November 25, 2024. The contract does not have a set-aside designation, indicating it was competitively awarded. Amerisourcebergen holds a significant $999,999,999 Indefinite...
This federal contract award, with the ID SPE2DB22D2206|SPE2DB25FEW10, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $35,936.78, is a delivery order contract with a firm fixed price pricing type. The contract covers the procurement of WELIREG 40 MG TABLET 90S, a pharmaceutical product, with a period of performance through January 17, 2025. AmerisourceBergen holds a...
  • SPE2DB24D3014
    Indefinite Delivery Contract
  • SPE2DB24D3014-SPE2DB25FKRVP
    Delivery Order

This federal contract award, with an ID of SPE2DB24D3014|SPE2DB25FKRVP, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,014.68 firm fixed-price delivery order is for the supply of Reyvow 50 mg tablets, with a performance period running through October 2024. This contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation, covering similar medical commodities. These contracting mechanisms enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

Generated 1/22/25, 12:59 AM